Single nucleotide variants in APOE were described as determinants for receptor interaction rates and risk factors for atherosclerosis, hypercholesterolemia or Alzheimer disease [62]. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.